abstract |
The present invention discloses novel uses and treatments including carvegoline, pramipexole, and novel combination formulations of carvegoline and pramipexole for use in the treatment of patients. Herein we disclose the use of carvegoline or pramipexole for treating PSP and MSA. Also disclosed is a combination therapy of cabergoline and pramipexole, which is simultaneously provided to patients in need of treatment of various central nervous system diseases, particularly Parkinson's disease (PD), and also PSP and MSA. |